Defining and measuring physicians’ responses to clinical reminders  by Vashitz, Geva et al.
Journal of Biomedical Informatics 42 (2009) 317–326Contents lists available at ScienceDirect
Journal of Biomedical Informatics
journal homepage: www.elsevier .com/locate /y jb inDeﬁning and measuring physicians’ responses to clinical reminders
Geva Vashitz a,*, Joachim Meyer a, Yisrael Parmet a, Roni Peleg a,b, Dan Goldfarb b,
Avi Porath a,c, Harel Gilutz a,c
aBen–Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel
bClalit Health Services, Beer–Sheva, Israel
c Soroka University Medical Center, Beer–Sheva, Israela r t i c l e i n f o
Article history:
Received 10 April 2008
Available online 26 October 2008
Keywords:
Guidelines
Decision aids
Medical decision support systems
Treatment gap
Cholesterol
Dyslipidemia
Compliance
Reliance
Spillover
Reactance
Cognitive engineering1532-0464/$ - see front matter  2008 Elsevier Inc. A
doi:10.1016/j.jbi.2008.10.001
* Corresponding author. Fax: +972 8 647 2958.
E-mail address: gevava@bgu.ac.il (G. Vashitz).a b s t r a c t
Decision-support systems, and speciﬁcally rule-based clinical reminders, are becoming common in med-
ical practice. Despite their potential to improve clinical outcomes, physicians do not always use informa-
tion from these systems. Concepts from the cognitive engineering literature on users’ responses to
warning systems may help to deﬁne physicians’ responses to reminders. Based on this literature, we sug-
gest an exhaustive set of possible responses to clinical reminders, consisting of four responses named
‘‘Compliance”, ‘‘Reliance”, ‘‘Spillover” and ‘‘Reactance”. We suggest statistical measures to estimate these
responses and empirically demonstrate them on data from a large-scale clinical reminder system for sec-
ondary prevention of cardiovascular diseases. There was evidence for Compliance, probably since the
physicians found the reminders informative, but not for Reliance, in line with the notion that Compliance
and Reliance are two distinct types of trust in information from decision-support systems. Our research
supports the notion that CDSS can promote closing the treatment gap and improve physicians’ adherence
to guidelines.
 2008 Elsevier Inc. All rights reserved.1. Introduction
1.1. Biomedical informatics and adherence to evidence-based medicine
The control of cardiovascular risk factors such as dyslipidemia,
hypertension and diabetes mellitus are crucial for preventing car-
diovascular disease (CVD) and is a major public health challenge.
CVD is a leading cause for morbidity and mortality in the western
world, accounting for almost 40% of US deaths [1]. In spite of the
existence of established guidelines [2,3], and clinically effective
interventions [4–6], there is a wide treatment gap between evi-
dence based guidelines and practice. Various epidemiologic studies
have shown that care for patients with chronic conditions, includ-
ing diabetes and coronary artery diseases, remains inadequate [7–
11]. Care is likely to improve when clinicians implement guide-
lines. For instance, Micieli et al. [12] demonstrate an association
between adherence to guidelines and stroke outcome.
Several frameworks for complex, multi-step, longitudinal care
plans (i.e., guidelines), which can handle incremental execution of
care plans over long time periods, have been developed to improve
adherence to guidelines (e.g., Arden [13], RÉSUMÉ [14], Asgaard Pro-ll rights reserved.ject and the Asbru Language [15], GLIF [16–18], Proforma [19], Prod-
igy [20], Protégé [21], EON [22], GUIDE [23] and DeGeL [24]).
Panzarasa et al. [25] recently described a real–time interface to alert
clinicians about non-compliance in a stroke unit. A relatively simple
form of these interventions is computerized reminders (CR), which
have become a major component in many adherence interventions
[26]. These systems collect clinical data and generate rule-based
patient-speciﬁc reminders and suggestions for physicians at the
point-of-care, based on the automated abstraction of guidelines.
They can remind physicians about important preventive care ac-
tions, which physicians may miss in their overloaded clinical rou-
tine. Back in 1976, McDonald [27] wrote about the ‘‘non-
perfectability of man”, pointing to the potential of clinical remind-
ers to reduce clinical errors, and stating that these errors are fre-
quently due to human limitations as a data processor rather than
to correctable human deﬁciencies. The effects of clinical reminder
systems were extensively studied in some reviews [28–30]. Many
studies showed positive effects [31–34], but others found only lim-
ited and variable use of information from these systems [35–41].
Some well-known barriers to adherence with clinical reminders
exist. Sequist et al. [35] mentioned factors such as lack of time,
poor patients’ compliance, and physicians’ lack of knowledge of,
or awareness to, or disagreement with speciﬁc guideline. Patterson
and her colleagues [42–45] referred to the integration of reminders
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tional issues, such as workload, training, false alarms and team
coordination. In a recent survey [46] physicians stated that they
were more likely to accept alerts concerning elderly patients and
patients with many chronic clinical conditions, and that they were
less likely to accept alerts when they were behind schedule. An-
other study [47] found higher completion rates of computerized
reminders among residents compared to staff providers and a po-
sitive effect of feedback to providers on completion.
Apparently more empirical and theoretical work is needed to
understand physicians’ responses to clinical reminders and to
specify the characteristics of a clinical reminder system that will
be accepted by physicians. One possible way to address this issue
is to look for relevant concepts in related ﬁelds. Particularly rele-
vant may be research on cognitive engineering, the interdisciplin-
ary approach to designing computerized systems intended to
support human performance [48]. Speciﬁcally, ﬁndings and con-
cepts regarding users’ responses to warning systems and alarms
may be relevant for understanding responses to clinical reminders.
1.2. Parallels between warnings and clinical reminders
Warnings, alerts or alarms inform users about the occurrence of
situations which require special attention, or immediate action in
extreme cases. Examples are smoke alarms, alerts in clinical inten-
sive care units, alarms in nuclear power plant control rooms, colli-
sion avoidance systems in aviation and surface transportation, etc.
A fairly large literature deals with human responses to warning
systems [49–55]. Research has shown that users are sensitive to
the predictive value of such systems, but the use of the information
they provide may be suboptimal. At times people may respond
excessively to warnings and ignore other information [56], while
at other times people may respond insufﬁciently to warnings,
especially when there are frequent unjustiﬁed alarms (e.g., ‘‘disuse
of automation” [57]). Because of the similarities between warning
systems and clinical reminder systems, users’ responses to these
systems are comparable.
1.2.1. Compliance and Reliance
Meyer [58] proposed that the effectiveness of warning systems
is strongly related to users’ trust, which consists of two distinct
components: Compliance and Reliance. Compliance is the ten-
dency to perform an action when a warning system instructs the
user to perform a corrective or preventive action, such as checking
a hospitalized patient’s status when a clinical monitor issues an
alert. Reliance, on the other hand, is the tendency to refrain from
performing an action when the warning system does not indicate
that it is necessary, e.g., assuming that the patient’s status is nor-
mal and thus not checking the patient, when the monitor does
not generate an alert. Recent studies [56,58–61] support the notion
that these are two distinct types of trust in warning systems, as
indicated by various variables affecting them differentially.
The distinction between Compliance and Reliance may also be
relevant for clinical reminder systems. In clinical reminders, Com-
pliance would be the tendency to act according to a reminder given
by a reminder system. For example, if a system suggests that a cer-
tain test should be done, Compliance would be indicated by an in-
creased tendency on the part of the physician to perform this test.
In contrast, Reliance would express itself as a decreased tendency
to refer a patient to a speciﬁc test as long as the clinical reminder
system does not indicate that the patient should undergo the test.
We identify two complementary responses to Compliance and
Reliance, named ‘‘Spillover” and ‘‘Reactance”, described below.
These four responses constitute an exhaustive set of possible re-
sponses to clinical reminders, when analyzing the probability of
acting upon receiving a reminder.1.2.2. Spillover
Spillover is the spread or expansion of responses, activities,
ideas or roles from one instance, system or domain to another.
For example, studies on trafﬁc safety have shown Spillover effects,
e.g., speeding decreased on both speed enforced roads and on near-
by non-enforced roads [62,63], and red-light running decreased at
camera enforcement locations and at nearby non-enforcement
locations as well [64,65]. On the other hand, a study [66] about
the impact of child safety belt laws on parents’ behavior found
no Spillover effect was found from belting young children to older
children.
We suggest that Spillover effects may also appear as responses
to clinical reminders. For example, a physician who receives
reminders about the possibility of a speciﬁc disease in certain pa-
tients may become more prone to diagnose the disease in patients
for whom no reminders were issued. Spillover is an opposite re-
sponse to Reliance. When a physician does not receive a reminder,
he or she may either ‘‘rely” on the reminder system, assuming that
no action should be taken, or may ‘‘spillover” by performing ac-
tions even when they were not indicated by the reminder system.
Zanetti et al. [67] showed that reminders for intraoperative drugs
increased re–dosing even in a control group which did not receive
reminders, probably because of increased awareness to the impor-
tance of re-dosing, which spread from physicians who received
reminders to others who did not receive reminders. Also, FDA advi-
sory about the risk of suicidality in pediatric patients taking certain
drugs had a Spillover effect into community treatment for adults
with depression, despite the focus of the policy on pediatric pa-
tients [68].
1.2.3. Reactance
Psychological Reactance is an unpleasant motivational state, in
which people react to situations they feel their autonomy is threa-
tened, in ways that reafﬁrm their freedom and autonomy. The
Reactance phenomenon was ﬁrst described in social psychology
[69,70] and in consumer behavior research [71]. For example, advi-
sory labels concerning violent television programs drew people to
watch these programs [72,73], and advisory labels on consumption
of fat products increased the desire to taste these products [74].
Similar reactions were found in alcohol consumption advisory la-
bels [75] and adolescents’ reaction to anti–smoking campaigns
[76].
Reactance to clinical reminders may exist when physicians
experience a threat to their autonomy or freedom of choice in
the presence of these systems. Reminder systems and decision-
support systems in general might be perceived by physicians as
replacing or degrading their traditional duties, and consequently
they may feel threatened by the inclusion of these systems in the
treatment continuum. For example, physicians who are advised
by a reminder system about therapeutic actions for their patients
may feel their autonomy is threatened, and may consciously or
unconsciously react by either ignoring the reminders or choosing
a different course of action, trying to regain their sense of freedom
and autonomy. Reactance is an opposite response to Compliance.
When a physician receives a reminder, he or she may either ‘‘com-
ply” with it by taking the recommended actions, or may ‘‘react” by
ignoring them or taking opposite actions to those recommended by
the reminder. This response was theoretically described regarding
physicians’ decision-making following pharmacotherapy recom-
mendations [77]. Tierney et al. [38] mentioned that given the lack
of physicians’ enthusiasm to follow computer–based chronic care
suggestions, they might rebel at the notion of the computer telling
them how to manage their patients.
Organizational issues, such as workload, may lower Compliance
and Spillover and increase Reliance and Reactance. Physicians’
characteristics may affect the four responses — e.g., residents
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quent false alarms may lower the trust in the system and in par-
ticular Compliance. Unfamiliarity with guidelines can lower
Compliance and Reliance, but it may also increase them, because
the physician may view the reminder system as a valid and up-
dated source of information. Physician’s disagreement with spe-
ciﬁc guidelines may lower Compliance and Reliance.
2. Measuring the four responses
2.1. Measuring responses to information with probabilities
We suggest that Compliance, Reliance, Spillover and Reactance
are four possible responses to information from clinical reminder
systems. The question arises how these responses can be mea-
sured. To do so, it is not sufﬁcient to determine whether a physi-
cian took an action recommended by a reminder, because it is
very well possible that a physician may have taken the action
even without receiving the reminder. Responses should be esti-
mated by comparing probabilities of actions taken by physicians
who receive reminders, to these probabilities for physicians who
do not receive reminders. With an adherence assessment algo-
rithm (described below) we can estimate if a physician followed
a reminder (i.e., the expected therapeutic action was taken), cat-
egorizing each reminder as ‘‘adhered” or ‘‘not adhered”. Using
this categorization, we can estimate the response probabilities
to reminders, i.e., the ‘‘Adherence rate” (Eq. (1)):
Adherence rate ¼ Number of reminders‘‘adhered‘‘
Total reminders sent
ð1Þ
Reminders are often triggered by events or changes in the
world, which generate conditions that justify issuing a reminder.
For instance, a clinical reminder may suggest referring a patient
to mammography if she has reached a certain age and has a famil-
ial history of breast cancer. Physicians may act differently when a
reminder system is available or not (e.g., they may be more prone
to act upon a patient having certain risk factors if they receive a
relevant reminder). They may also act differently when the condi-
tions for a reminder are met or not met (e.g., they may be more
likely to refer a patient above certain age and with familial history
of breast cancer to mammography, than a patient without these
conditions, regardless whether a reminder was given or not).
Although a reminder system may be available, the conditions
for a reminder may currently not be met for a speciﬁc patient,
or, when a reminder system is unavailable, the conditions for a
‘‘reminder” can be met. The combinations of a reminder system
being available or not and conditions for a reminder being met
or not are shown in Table 1.
When the conditions for issuing a reminder are met (‘‘C”), we
denote PAjðC\SÞ as the probability that a physician will take actions
(‘‘A”) when he or she gets reminders from an available reminder
system (‘‘S”), and PAjðC\SÞ as the probability that a physician will
take actions when no reminder system is available (‘‘S”; i.e., if a
reminder system would have been available, it would have re-
minded the physician to take an action). This is actually the prob-
ability that the physician will take actions as a routine practice.
When the conditions for a reminder are not met (‘‘C”; i.e., an ac-
tion is not necessarily recommended), we denote PAjðC\SÞ as the
probability that a physician will take actions (‘‘A”) when a remin-
der system is available (‘‘S”), but did not generate a reminder be-
cause the conditions for a reminder were not met, and PAjðC\SÞ as
the probability that a physician will take actions (‘‘A”) when no
reminder system is available (‘‘S”; i.e., if a reminder system would
have been available, it would not have advised the physician to
take an action). If we regard the physician’s action as a binary
320 G. Vashitz et al. / Journal of Biomedical Informatics 42 (2009) 317–326event (acts or does not act), the probabilities not to act are the cor-
responding complementary probabilities to the ones mentioned
above ðPAjði\jÞ ¼ 1 PAjði\jÞ; i 2 fC; Cg; j 2 fS; SgÞ.
2.2. Estimating differences between probabilities
Statistical measures can be used to estimate differences be-
tween the probabilities to respond to reminders when the condi-
tions for a reminder are met and not met, and when a reminder
system is available or unavailable. We suggest three measures:
absolute risk, relative risk, and odds ratio, which are estimated
on 2 2 contingency tables. Absolute risk (AR) denotes the abso-
lute difference between probabilities of two events. The absolute
risk of event A with probability PA and event B with probability
PB is AR = PA  PB, and AR = 0 indicates that the probabilities of
the event to occur are similar in both events. For example, if
PA = 0.03 and PB = 0.01, A is more probable to occur than B by 0.02.
Relative risk (RR) is the ratio of the probability of the event
occurring in one group to the probability of the event in another
group (RRA/B = PA/PB) (e.g., PExposure/PControl). In the example above,
RR = 0.03/0.01 = 3, which means that event A is 3 times more likely
to occur than event B. Odds Ratio (OR) compares the odds of an
event to occur between two groups (e.g., exposure vs. control).Table 2
Properties of AR, ln(RR) and ln(OR).
Measure Formula Range
ARA/B p^A  p^B 1 6 A^R 6 þ1
ln(RRA/B) lnðp^A=p^BÞ 1 6 lnðR^RÞ 6  lnðp^BÞ
ln(ORA/B) lnðp^A=ð1p^AÞp^B=ð1p^BÞÞ 1 6 lnðO^RÞ 6 þ1
Note: a, b, c, and d are the four frequencies in the 2 2 contingency table for which the m
p^A ¼ aaþb and p^B ¼ ccþd .
Fig. 1. A comparison of (a) absolute risk, (b) ln (relative risk) and (The odds of an event with probability P to occur are the probability
of the event to occur divided by the probability of it not to occur,
e.g., win or loose, healthy or sick, etc. (Odds(P) = P/(1  P)). Hence,
the ratio between two odds (i.e., the odds ratio) is (Eq. (2)):
ORA=B ¼ OddsðPAÞOddsðPBÞ ¼
PA=ð1 PAÞ
PB=ð1 PBÞ ¼
PAð1 PBÞ
PBð1 PAÞ ; ð2Þ
which would be in our example, 0:03 ð1 0:01Þ=0:01
ð1 0:03Þ ¼ 3:06 .
RR and OR have an asymmetric range between (0,+1). The nat-
ural logarithm transformation on RR and OR can be employed to
generate symmetry in the measures. Moreover, the statistical
inference of RR, ln(RR), OR and ln(OR) is done by approximations
to a normal distribution approximation of the sampling distribu-
tions and not by the exact distribution. This approximation is more
accurate after the logarithmic transformation. RR = 1 and OR = 1
(and hence ln(RR) = 0 and ln(OR) = 0) indicate that the probabilities
of the event to occur are similar in the two groups. Table 2 presents
the properties of the measures:
2.2.1. Comparison between the suggested measures
AR, RR and OR compare the likelihood of an event to occur be-
tween two groups, but they may yield different estimates. WhileConﬁdence interval Standard error estimate
A^R  z1a=2s^eðA^R
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p^Að1p^AÞ
aþb þ p^Bð1p^BÞcþd
q
lnðR^RÞ  z1a=2s^eðlnðR^RÞÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
a  1aþbþ 1c  1cþd
q
lnðO^RÞ  z1a=2s^eðlnðO^RÞÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
a þ 1b þ 1c þ 1d
q
easures are computed (they are equivalent to the f frequencies in Table 1); hence,
c) ln (odds ratio) values for selected probabilities pairs (P1,P2).
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ities, they yield different estimates for large probabilities, and the
same rule applies for ln(RR) and ln(OR) (see Fig. 1). For example,
0.01–0.019 and 0.99–0.999 both have an AR of 0.009, but the RR
of the second pair is only about a half of that of the ﬁrst pair
(1.90 vs. 1.01, respectively), while the OR of the second pair is more
than 5 times greater than the OR of the ﬁrst pair (1.92 vs. 10.09,
respectively). Moreover, while the RR of the two pairs is about
the same (1.90 vs. 1.92, respectively), the OR of the second pair
is 10 times greater than the OR of the ﬁrst couple (1.01 vs. 10.09,
respectively). Hence, the distinction between RR and OR is espe-
cially important in medium to high probabilities.
As illustrated in Fig. 1, all measures are greater in absolute val-
ues when the algebraic difference between the two probabilities is
greater. AR increases (by deﬁnition) linearly with increasing alge-
braic difference between the probabilities, while ln(RR) and ln(OR)
have near-linear increase for intermediate probabilities (between
approximately 0.2 and 0.8). For a given value of p2, ln(RR) ap-
proaches 1 as p1 approaches 0 and  lnðp2Þ as p1 approaches 1.
In comparison, for a given value of p2, ln(OR) has symmetric behav-
ior and the center of symmetry is p1 = 0.5. It approaches 1 as p1
approaches 0 and þ1 as p1 approaches 1.
One drawback of RR is that it cannot be estimated in case-con-
trol studies, while AR and OR can be estimated for any type of
study. Another advantage of OR is that it is easily adjusted for con-
founding variables, while the adjustments of RR are more complex.
A simple way to adjust OR for a covariate is the logistic regression,
in which the covariate is formulated in terms of OR and ln(OR)
[78].
2.3. Estimating the four responses with the statistical measures
We can deﬁne the behavioral responses (Compliance, Reliance,
Spillover and Reactance) using the described statistical measures.
We denote ARC ¼ PAjðC\SÞ  PAjðC\SÞ as the absolute ‘‘risk”, lnRRC ¼
lnðPAjðC\SÞ=PAjðC\SÞÞ as the ln-transformed relative risk and
lnORC ¼ lnððPAjðC\SÞ  ð1 PAjðC\SÞÞÞ=ðPAjðC\SÞ  ð1 PAjðC\SÞÞÞÞ as the
ln-transformed odds ratio to take actions when conditions for a re-
minder are met, when a reminder system is available or not (see
Table 2). Similarly, ARC ¼ PAjðC\SÞ  PAjðC\SÞ, and lnRRC ¼
lnðPAjðC\SÞ=PAjðC\SÞÞ and lnORC ¼ lnððPAjðC\SÞ  ð1 PAjðC\SÞÞÞ=ðPAjðC\SÞ
ð1 PAjðC\SÞÞÞÞ compare the probabilities to take action when the
conditions for a reminder are not met, when a reminder system
is available or unavailable.
Compliance exists when PAjðC\SÞ > PAjðC\SÞ (i.e., ARC > 0,
ln(RRC) > 0 and ln(ORC) > 0), because the probability that a physi-
cian will take action when the conditions for a reminder are met
is greater when a reminder system is available than when it is
unavailable. In contrast, Reactance exists when PAjðC\SÞ < PAjðC\SÞ
(i.e., ARC < 0, ln(RRC) < 0 and ln(ORC) < 0), because the probability
that a physician will take actions when the conditions for a remin-
der are met is lower when a reminder system is available than
when it is unavailable (see Fig. 2a). Spillover exists when
PAjðC\SÞ > PAjðC\SÞ (i.e., ARC >0, lnðRRCÞ > 0 and lnðORCÞ > 0Þ, because
the probability that a physician will take actions when the condi-
tions for a reminder are not met is greater when a reminder system
is available than when it is unavailable. In contrast, Reliance exists
when PAjðC\SÞ < PAjðC\SÞ (i.e., ARC < 0, lnðRRCÞ < 0 and lnðORCÞ < 0),
because the probability that a physician will take actions when
the conditions for a reminder are not met is lower when a remin-
der system is available than when it is unavailable (see Fig. 2b).
When PAjðC\SÞ ¼ PAjðC\SÞ (i.e., ARC=0, ln(RRC)=0 and ln(ORC)=0) or
PAjðC\SÞ =PAjðC\SÞ (i.e., ARC ¼ 0, lnðRRCÞ ¼ 0 and lnðORCÞ ¼ 0), the prob-
abilities to take actions are the same with or without a reminder
system, indicating the physician ignores the reminder. The four re-
sponses can be depicted in a space, divided into 4 zones accordingto the value of the measures (whether they are positive or nega-
tive) and according to whether the conditions for a reminder are
met (see Fig. 3).3. Empirical demonstration of the methodology
Data from the ‘‘Computerized Community Cholesterol Control”
(4C) intervention program [79], which is based on a large–scale
clinical reminder system, can be used to demonstrate the compu-
tation of the measures and to estimate the extent to which the four
responses are evident in physicians’ actions.
3.1. Setting and design
The 4C intervention program aims to promote prevention of
cardiovascular diseases. It was initiated and is maintained by Sor-
oka University Medical Center, a 1000-bed tertiary academic hos-
pital, and ‘‘Clalit Health Services”, which is the largest HMO in
Israel, serving more than 3.6 million patients nationwide,
500,000 of them in the southern district of Israel, which is served
by Soroka University Medical Center. The clinics in the district
were divided into intervention and control clinics with demo-
graphic matching. A computerized algorithm reevaluated each pa-
tient status every 4 months and generated a reminder. Reminders
were actually sent to physicians in the intervention clinics and
were not sent in the control clinics. A full run of the protocol with
the 56 intervention clinics and 56 control clinics was done be-
tween September 2002 and January 2004. From January 2004 the
reminders were sent to all district clinics (144 clinics), eliminating
the distinction between the intervention and control clinics. The
project involved 14,018 patients from the 144 clinics. The remind-
ers were delivered to the physicians as paper hardcopies. Each re-
minder letter was personally signed by one of the project’s
administrating physicians. Since the reminders were based on
international evidence-based clinical guidelines, physicians in the
control group should take the same actions as physicians in the
intervention group, even without receiving the reminders.
3.2. Subjects and sample selection
The intervention enrolled patients aged 20–80 years old, who
were members of the ‘‘Clalit Health Services” HMO, and discharged
from Soroka University Medical Center between 2001 and 2004
with a diagnosis of clinical atherosclerosis (coronary artery disease,
peripheral vascular disease, cerebrovascular accidents and stroke,
ICD-9 codes: 410–414, 428, v36.0, v45.81 and v45.82). Patients in
‘‘Clalit Health Services” are associated with a primary care physi-
cian in a primary care clinic in their residential neighborhood.
We excluded reminders for several reasons (e.g., relatively rare
reminders such as diet recommendations, reminders with missing
information about the physician, reminders which were generated
but were not delivered due to a physician’s speciﬁc request, and
reminders sent to physicians who worked in both an intervention
and a control clinic). Eventually the dataset included data on
22,815 reminders. The researchers obtained local ethics committee
approval for the protocol.
3.3. Descriptive statistics
We analyzed data on 22,815 reminders, sent to 57 clinics (inter-
vention group: 29 clinics, 50.9%; control group: 28 clinics, 49.1%).
The reminders were sent to 139 physicians in these clinics (inter-
vention group: 70 physicians, 50.4%; control group: 69 physicians,
49.6%) over a 16-month period (September 2002–January 2004),
regarding 8563 patients (intervention group: 4,422, 51.6%; control
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Fig. 2. (a) Probabilities to follow a reminder when the conditions for the reminder are met. The difference between the probabilities to follow the reminder when a reminder
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reminders per patient on average). The different reminder types
were equally distributed among the two groups (see Table 3).
3.4. Reminder types
The reminders were based on the evidence-based clinical guide-
lines [2,3] for cholesterol management. These guidelines recom-
mend that patients with risk factors for heart disease and stroke
(such as hypercholesterolemia, diabetes, hypertension, obesity,
smoking, familial history of heart diseases, etc.) should be moni-
tored and treated for these risk factors. In line with the guidelines,
each reminder included, in addition to a clinical summary of the
patient, one of the following recommendations: (1) lipids screen-
ing (if the patient was not screened for LDL-C within the last 6
months); (2) pharmacotherapy with lipids lowering drugs (if high
lipids levels were found); or (3) referral to metabolic consultation
(if the patient was already treated with lipids lowering drugs, and“Spillover”
“Reliance”
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, l
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Fig. 3. Representation of Compliance, Reliance, Spillover and Reactance in one
space.the lipids levels did not improve over time). These reminder types
represent cases in which the conditions for a reminder are met (‘‘C”
as deﬁned above). If the patient was within the clinical target levels
according to the guideline, a ‘‘patient in target levels” indication
was generated by the algorithm but no physical reminder was sent
to the physician. This status corresponds to the ‘‘conditions for a
reminder are not met” condition (‘‘C” as deﬁned above).
3.5. Adherence assessment algorithm
In order to assess the physicians’ adherence with the reminders,
each reminder was categorized as ‘‘adhered” or ‘‘not adhered”
according to the association between the reminder and the actual
action taken by the physician. Lipids screening reminders were cat-
egorized as ‘‘adhered” if lipids screening was performed within 4
months after the reminder was sent. Pharmacotherapy reminders
were categorized as ‘‘adhered” if the physician prescribed a lipids
lowering drug to the patient within 4 months after the reminder
was sent. Metabolic consultation reminders were categorized as
‘‘adhered” if a metabolic specialist physician consultation was
made within 6 months after the reminder was sent. The ‘‘patient
in target levels” cases were categorized as ‘‘adhered” if the physi-
cian indeed did not take any action within 4 months after the re-
minder was sent. Otherwise, if the physician did take an action,
the ‘‘no reminder” was categorized as ‘‘not adhered”.
The response periods (time lags between the delivery of the re-
minder and the matched action) were set to 4 months and even 6
months for two reasons. First, the reminder letters were sent as
hardcopies, and some time passed until the physicians received
them. Second, adherence could only be measured if the patient
actually met the physician. Most patients visit the clinics intermit-
tently, so that a patient may not meet the physician for several
months. We chose relatively long intervals to increase the likeli-
hood that the patient did meet the physician.
When a physician receives a reminder, he or she may either fol-
low it exactly, or take another diagnostic or therapeutic action,
which may or may not be explicitly mentioned in the reminder.
For example, if a physician received a lipids screening reminder
and lipids screening was done, the reminder was categorized as
‘‘adhered exactly” (namely ‘‘exact” adherence). If any kind of action
was taken (lipids screening, drug prescription or metabolic consul-
tation), the reminder was categorized as ‘‘adhered broadly”
G. Vashitz et al. / Journal of Biomedical Informatics 42 (2009) 317–326 323(namely ‘‘broad” adherence). The ‘‘exact” and ‘‘broad” adherences
are different ways to measure adherence, with the ‘‘broad” adher-
ence being an upper limit to the ‘‘exact” adherence (PExact 6 PBroad),
because if the reminder was followed exactly, it was by deﬁnition
followed broadly, but not vice versa.
3.6. Statistical analysis
Based on the adherence assessment, we calculated the esti-
mated response probabilities (PAjðC\SÞ, PAjðC\SÞ, PAjðC\SÞ and PAjðC\SÞ)
for each reminder type and for each adherence type (‘‘exact” and
‘‘broad”). Using these probabilities we estimated the statistical
measures (AR, ln(RR) and ln(OR)) and their conﬁdence intervals
(95% CI) for statistical inference, and deduced the Compliance, Reli-
ance, Spillover and Reactance.
3.7. Compliance, Reliance, Spillover and Reactance
The absolute and relative differences in probabilities to adhere
with the reminders are shown in Table 3 and Fig. 4. The results
show evidence for a Compliance effect in all reminder types in
the ‘‘exact” adherence and in lipids screening and pharmacother-
apy reminders in the ‘‘broad” adherence.
4. Discussion
Borrowing terms from the cognitive engineering and consumer
research literature, we described four responses to clinical remind-
ers — Compliance, Reliance, Spillover and Reactance and our data
showed existence of Compliance.
4.1. The four responses
4.1.1. Compliance and Reliance
Compliance and Reliance were originally identiﬁed as two dis-
tinct expressions of trust in automation in the speciﬁc context of
warning systems [56], but they can also appear as responses to
clinical reminders. The Compliance effect found here corresponds
with results of previous studies [56,58–61], which showed Compli-
ance to warning systems. In contrast to results in other domains
[56,58], we found no evidence for Reliance. The absence of Reliance
here may be attributed to the speciﬁc domain and settings. The
ﬁnding of Compliance without Reliance strengthens the notion
that these are two distinct responses to information.
Our system reminded the physicians only if an action was re-
quired. It generated no physical reminder if the patient was in tar-
get levels (i.e., the conditions for a reminder were not met).
Reliance in this context means to refrain from performing an actionTable 3
Differences between the study groups in adherence to reminders (n = 22,815)
n (%) Exact adheren
Reminder type Intervention Control Total PAjðC\SÞ PAjðC\
Conditions for reminder are met (C)
Cholesterol screening 3934 (34.0) 4433 (39.4) 8367 (36.7) 0.487 0.41
Pharmaco-therapy 2427 (21.0) 2393 (21.3) 4820 (21.1) 0.173 0.11
Specialist consultation 750 (6.5) 586 (5.2) 1336 (5.9) 0.080 0.05
Conditions for reminder are not met (C)
Intervention Control Total PAjðC\SÞ PAjðC\
Patient in target levels 4451 (38.5) 3841 (34.1) 8292 (36.3) 0.216 0.22
Total 11,562 (100) 11,253 (100) 22,815 (100)
Note: This table presents the absolute and relative differences between the study group
(‘‘Exact” and ‘‘Broad”).
* p < .05 signiﬁcance.when the system does not indicate that it is necessary. In other
cases, the system may explicitly recommend not to perform an ac-
tion (e.g., ‘‘This patient should NOT be treated by drug X”). Compli-
ance in this context means to refrain from performing an action
when the system explicitly indicates one should refrain.
As mentioned above, Compliance and Reliance were ﬁrst de-
scribed in the context of responses to warning systems. Warning
systems and clinical reminders are similar in many respects, but
there are also some important differences. Indications from warn-
ing systems and alarms usually refer to a particular moment in
time. Users are supposed to respond to them in a certain way,
and failure to adhere to them may have serious consequences.
Reminders are typically used to improve various facets of common
clinical practices, such as screenings and routine scheduling of pa-
tients for tests. Although there are many warning systems that are
critical and require continual levels of vigilance, there are others
which are similar to the reminder system studied here. One can
therefore consider both warnings and reminders as being on some
point on a criticality continuum, and the principles that apply to
one system can be applied to the other (and it is sometimes difﬁ-
cult to distinguish between the two systems).
4.1.2. Spillover and Reactance
In the context of clinical reminders, Spillover and Reactance
can emerge as well, but they are not expressions of trust in the
system (in contrast to Compliance and Reliance that can be seen
as indicating trust). Spillover results from positive experiences
with the system, which trigger the physician to consider actions
not explicitly advised by the system. The result for Spillover is
different from previous studies that showed Spillover in clinical
reminders [67] and clinical advisory messages [68], probably
due to the different setting. Reactance results from negative expe-
riences with the system, which trigger feelings of impaired auton-
omy. Reactance effects were evident in other domains [72–74],
but not in clinical domains. The absence of a Reactance effect
can be explained by the generally positive attitude of the physi-
cians who participated in the project towards the computerized
reminders, as informally expressed in personal interviews we
conducted.
4.2. Measuring the responses by probabilities and statistical measures
One cannot know for sure if a speciﬁc physician’s action was a
direct result of the reminder or a routine practice. The responses
to the reminders need to be estimated by comparing probabilities.
If the likelihood of performing an action after receiving a reminder
is greater than the likelihood of performing the action without a re-
minder, the physicians seem to respond to the reminders.ce Broad adherence
SÞ ARC ln(RRC) ln(ORC) PAjðC\SÞ PAjðC\SÞ ARC ln(RRC) ln(ORC)
0 0.077* 0.173* 0.314* 0.650 0.602 0.048* 0.077* 0.205*
9 0.054* 0.376* 0.440* 0.781 0.720 0.061* 0.081* 0.326*
1 0.029* 0.446* 0.477* 0.831 0.814 0.017 0.020 0.114
SÞ ARC lnðRRCÞ lnðORCÞ PAjðC\SÞ PAjðC\SÞ ARC lnðRRCÞ lnðORC Þ
8 0.012 0.054 0.069 0.784 0.772 0.012 0.015 0.069
s in the probabilities to adhere to reminders, by reminder type and adherence type
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responses to reminders. They can often be obtained from archival
data, as was done in the current study, and they do not require
physicians’ active participation in the study or direct observations
which may affect physicians’ actions. Also, measures derived from
probabilities are probably the most relevant ones, considering that
reminders are usually supposed to affect the tendency to act. The
four responses presented here constitute an exhaustive set of pos-
sible responses computed from probabilities. Nevertheless, proba-
bilities are not the only data from which responses to reminders
can be computed. Additional measures of responses to reminders
can be derived from response time, the tendency to consult other
information sources, surveys, etc. Analyses of these measures,
and their comparison to the probability-based measures intro-
duced here may have great value for understanding the way
reminders are processed and affect actions.
One challenge with using the existing data for computing the
probabilities and the different measures is that some data refer to
patient actions as a consequence of the reminder (namely, the lipids
screening and themetabolic consultation). In these cases, for adher-
ence to be detected, the physician had towrite a referral and the pa-
tient had to undergo the test or attend the consultation. Thus,
compliance here is actually a combination of the physician’s com-pliance and the patient’s compliance. Any measure of compliance
here is therefore a lower limit measure of physicians’ compliance.
4.2.1. Comparison between the statistical measures
We applied three statistical measures (AR, ln(OR) and ln(RR))
to estimate the responses. Since the probabilities were relatively
small (p < 0.5 for lipids screening and p < 0.25 for the other
reminders), the general pattern obtained from the three mea-
sures was similar. Yet, as mentioned above, differences would
have emerged if the probabilities were high, especially between
the ln(RR) and ln(OR). It is therefore reasonable to employ mul-
tiple measures for quantifying the different responses. Table 3
and Fig. 4 demonstrate the importance of estimating adherence
by the different measures. Even though the results regarding
the responses were similar in the three measures, different pat-
terns were evident in different reminder types and adherence
types. For example, in the ‘‘exact” adherence, AR decreased
across the different reminder types, while ln(RR) and ln(OR) in-
creased. This means that in absolute values, the likelihood to fol-
low the reminders between the two groups decreased across the
different reminder types, while in relative values, the likelihood
increased. In the ‘‘broad” adherence, AR, ln(RR) and ln(OR) in the
pharmacotherapy reminders were greater than in the lipids
G. Vashitz et al. / Journal of Biomedical Informatics 42 (2009) 317–326 325screening reminders, which were greater than in the metabolic
consultation reminders.
4.3. Implications of the methodology
Designers of clinical reminders should always wish for Compli-
ance, and never wish for Reactance. Reliance is preferred if the pre-
dictive value of the system is high and the actions suggested by the
system are costly, unnecessary or potentially dangerous (i.e., when
it is better to refrain from taking actions when they are not recom-
mended by the system). Similarly, Spillover is preferred for actions
that are justiﬁed and cost-effective, but for some reason no remin-
der was given about them. In this case, however, the health care
system would actually not need personalized reminders and
should instead instruct physicians to take certain actions regarding
all patients with speciﬁc conditions. This analysis demonstrates
that the optimal response to a reminder depends on the expected
value of taking an action and the perceived predicted value by the
physician. For example, in the speciﬁc project, reminders were tar-
geted at the secondary prevention population, yet the primary pre-
vention population can beneﬁt from these reminders as well, given
that the treatment is proven to be cost-effective. Most physicians
treat both primary and secondary prevention populations, and
therefore there may be a Spillover of the treatment from the sec-
ondary to primary prevention population (and vice versa).
Since the physician usually knows more than the reminder sys-
tem, and due to the possibly negative reactions to reminder sys-
tems mentioned above (e.g., Reactance, and other unintended
consequences such as low perceived validity, alert fatigue and
other negative emotional effects on physicians [80]), an optimal re-
minder system should probably point the physician to some issues
that require attention or suggest therapeutic opportunities rather
than give strict instructions to the physicians. With this in mind,
we estimated both ‘‘exact” and ‘‘broad” adherence to reminders.
Conceivably, physicians may use the reminders as indications for
preferred actions, but decide on the speciﬁc action they take, con-
sidering their familiarity with the patient and additional factors.
This would lead to relatively low ‘‘exact” adherence, but high
‘‘broad” adherence.
The methodology and four responses to reminders described
here are not limited to physicians. With additional data, it is possi-
ble to apply the analysis of Compliance, Reliance, Spillover and
Reactance at the patient level as well. Such analyses may show
whether patients are more likely to take certain actions (e.g., buy
non-prescription drugs such as aspirin) after being instructed by
their physician.
5. Conclusions
In this paper we (1) drew parallels between warnings and clin-
ical reminders; (2) proposed an exhaustive set of four responses to
reminders, based on Meyer’s [56] distinction between Compliance
and Reliance as two different responses to warning systems, to
which we added the Spillover and Reactance responses; (3) sug-
gested statistical measures to estimate these responses; and (4)
demonstrated the suggested methodology on data from a large-
scale, real-life clinical reminder system.
The results show evidence for Compliance. Although Spillover
and Reliance are plausible responses to clinical reminders, they
were not evident in the data. Reactance is not a plausible response
in the clinical treatment context and indeed was not found in the
data. These results support the notion that Compliance and Reli-
ance are two distinct types of trust in information from warning
and decision-support systems. We assume that the key mechanism
which predicts these four responses is the perceived predictive va-lue of the clinical reminders by the physician. Most physicians
apparently perceived the reminders as cues for considering
whether an action should be taken, rather than as a highly predic-
tive information source whose recommendations should be strictly
followed.
The framework presented here can be applied to the analysis of
physicians’ responses to decision support systems in other do-
mains, as well as patients’ responses to information. Understand-
ing the way physicians and patients respond to these systems
can help us design better systems and develop appropriate train-
ing, increasing the chances for effective use of the information pro-
vided by decision-support systems.
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